1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Multiplex Assays Market
4. Executive Summary
5.
Voice of Customer
6.
Global Multiplex Assays Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By Product (Reagents & Consumables, Accessories & Instruments,
Software & Services)
6.2.2. By Type (Nucleic Acid, Protein, Cell-based)
6.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence,
Multiplex Real-Time PCR, Others)
6.2.4. By Application (Research & Development v/s Clinical Diagnostics)
6.2.4.1.
Research & Development (Drug Discovery & Development v/s
Biomarker Discovery & Validation)
6.2.4.2.
By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular
Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
6.2.5. By End User
(Pharmaceutical & Biotechnology Companies, Hospitals & Research
Institutes, Reference Laboratories, Others)
6.2.6. By Company (2021)
6.2.7. By
Region
6.3. Product
Market Map
7.
Asia-Pacific Multiplex Assays Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By Product (Reagents
& Consumables, Accessories & Instruments, Software & Services)
7.2.2. By Type (Nucleic
Acid, Protein, Cell-based)
7.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence,
Multiplex Real-Time PCR, Others)
7.2.4. By Application (Research & Development v/s Clinical Diagnostics)
7.2.4.1.
Research & Development (Drug Discovery & Development v/s
Biomarker Discovery & Validation)
7.2.4.2.
By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular
Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
7.2.5. By End User
(Pharmaceutical & Biotechnology Companies, Hospitals & Research
Institutes, Reference Laboratories, Others)
7.2.6.
By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1.
China Multiplex Assays Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Type
7.3.1.2.3.
By Technology
7.3.1.2.4.
By Application
7.3.1.2.5.
By End User
7.3.2.
India Multiplex Assays Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Type
7.3.2.2.3.
By Technology
7.3.2.2.4.
By Application
7.3.2.2.5.
By End User
7.3.3.
Japan Multiplex Assays Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Type
7.3.3.2.3.
By Technology
7.3.3.2.4.
By Application
7.3.3.2.5.
By End User
7.3.4.
South Korea Multiplex Assays Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Type
7.3.4.2.3.
By Technology
7.3.4.2.4.
By Application
7.3.4.2.5.
By End User
7.3.5.
Australia Multiplex Assays Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Type
7.3.5.2.3.
By Technology
7.3.5.2.4.
By Application
7.3.5.2.5.
By End User
8.
Europe Multiplex Assays Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By Product (Reagents
& Consumables, Accessories & Instruments, Software & Services)
8.2.2. By Type (Nucleic
Acid, Protein, Cell-based)
8.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence,
Multiplex Real-Time PCR, Others)
8.2.4. By Application (Research & Development v/s Clinical Diagnostics)
8.2.4.1.
Research & Development (Drug Discovery & Development v/s
Biomarker Discovery & Validation)
8.2.4.2.
By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular
Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
8.2.5. By End User
(Pharmaceutical & Biotechnology Companies, Hospitals & Research
Institutes, Reference Laboratories, Others)
8.2.6.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Multiplex Assays Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Type
8.3.1.2.3.
By Technology
8.3.1.2.4.
By Application
8.3.1.2.5.
By End User
8.3.2.
Germany Multiplex Assays Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Type
8.3.2.2.3.
By Technology
8.3.2.2.4.
By Application
8.3.2.2.5.
By End User
8.3.3.
United Kingdom Multiplex Assays Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Type
8.3.3.2.3.
By Technology
8.3.3.2.4.
By Application
8.3.3.2.5.
By End User
8.3.4.
Italy Multiplex Assays Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Type
8.3.4.2.3.
By Technology
8.3.4.2.4.
By Application
8.3.4.2.5.
By End User
8.3.5.
Spain Multiplex Assays Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Type
8.3.5.2.3.
By Technology
8.3.5.2.4.
By Application
8.3.5.2.5.
By End User
9.
North America Multiplex Assays Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By Product (Reagents
& Consumables, Accessories & Instruments, Software & Services)
9.2.2. By Type (Nucleic
Acid, Protein, Cell-based)
9.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence,
Multiplex Real-Time PCR, Others)
9.2.4. By Application (Research & Development v/s Clinical Diagnostics)
9.2.4.1.
Research & Development (Drug Discovery & Development v/s
Biomarker Discovery & Validation)
9.2.4.2.
By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular
Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
9.2.5. By End User
(Pharmaceutical & Biotechnology Companies, Hospitals & Research
Institutes, Reference Laboratories, Others)
9.2.6.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Multiplex Assays Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Type
9.3.1.2.3.
By Technology
9.3.1.2.4.
By Application
9.3.1.2.5.
By End User
9.3.2.
Mexico Multiplex Assays Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Type
9.3.2.2.3.
By Technology
9.3.2.2.4.
By Application
9.3.2.2.5.
By End User
9.3.3.
Canada Multiplex Assays Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Type
9.3.3.2.3.
By Technology
9.3.3.2.4.
By Application
9.3.3.2.5.
By End User
10.
South America Multiplex Assays Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1. By Product (Reagents
& Consumables, Accessories & Instruments, Software & Services)
10.2.2. By Type (Nucleic
Acid, Protein, Cell-based)
10.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence,
Multiplex Real-Time PCR, Others)
10.2.4. By Application (Research & Development v/s Clinical Diagnostics)
10.2.4.1. Research &
Development (Drug Discovery & Development v/s Biomarker Discovery &
Validation)
10.2.4.2. By Clinical
Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune
Diseases, Nervous System Disorders, Others)
10.2.5. By End User
(Pharmaceutical & Biotechnology Companies, Hospitals & Research
Institutes, Reference Laboratories, Others)
10.2.6.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Multiplex Assays Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Type
10.3.1.2.3.
By Technology
10.3.1.2.4.
By Application
10.3.1.2.5.
By End User
10.3.2.
Colombia Multiplex Assays Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Type
10.3.2.2.3.
By Technology
10.3.2.2.4.
By Application
10.3.2.2.5.
By End User
11.
Middle East and Africa Multiplex Assays Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1. By Product (Reagents
& Consumables, Accessories & Instruments, Software & Services)
11.2.2. By Type (Nucleic
Acid, Protein, Cell-based)
11.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence,
Multiplex Real-Time PCR, Others)
11.2.4. By Application (Research & Development v/s Clinical Diagnostics)
11.2.4.1. Research &
Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
11.2.4.2. By Clinical
Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune
Diseases, Nervous System Disorders, Others)
11.2.5. By End User
(Pharmaceutical & Biotechnology Companies, Hospitals & Research
Institutes, Reference Laboratories, Others)
11.2.6.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Multiplex Assays Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Product
11.3.1.2.2.
By Type
11.3.1.2.3.
By Technology
11.3.1.2.4.
By Application
11.3.1.2.5.
By End User
11.3.2.
Saudi Arabia Multiplex Assays Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Product
11.3.2.2.2.
By Type
11.3.2.2.3.
By Technology
11.3.2.2.4.
By Application
11.3.2.2.5.
By End User
11.3.3.
UAE Multiplex Assays Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Product
11.3.3.2.2.
By Type
11.3.3.2.3.
By Technology
11.3.3.2.4.
By Application
11.3.3.2.5.
By End User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
Competition Outlook
14.2.
Company Profiles
14.2.1.
Abbott Laboratories, Inc.
14.2.2.
Thermo Fisher
Scientific, Inc.
14.2.3.
Danaher Corporation
14.2.4.
F. Hoffmann-La Roche
AG
14.2.5.
Siemens Healthineers
AG
14.2.6.
Bio-Rad
Laboratories, Inc.
14.2.7.
bioMérieux SA
14.2.8.
BÜHLMANN
Laboratories AG
14.2.9.
Sekisui Medical Co.,
Ltd.
14.2.10.
Randox Laboratories
Ltd.
15. Strategic Recommendations
16. About Us & Disclaimer